<PAGE>
FILED PURSUANT TO RULE 424(b)(3)
REIGISTRATION FILE NO. 333-69227
SUPPLEMENT NO. 6 DATED SEPTEMBER 13, 2000
TO PROSPECTUS DATED JANUARY 28, 2000
RELATING TO $345,000,000 PRINCIPAL AMOUNT OF 7% CONVERTIBLE
SUBORDINATED NOTES DUE 2009 AND
10,515,087 SHARES OF
TOTAL RENAL CARE HOLDINGS, INC.
COMMON STOCK
The purpose of this supplement is to provide information regarding selling
securityholders in addition to those listed in the prospectus dated January 28,
2000, as supplemented by Supplement No. 1 dated February 24, 2000, Supplement
No. 2 dated March 20, 2000, Supplement No. 3 dated April 27, 2000, Supplement
No. 4 dated June 7, 2000 and Supplement No. 5 dated July 27, 2000, forming a
part of registration statement no. 333-69227 on Form S-3, or to update the
information regarding selling securityholders previously listed in the
prospectus.
The table has been prepared based upon information furnished to us by or on
behalf of the selling securityholder listed below. We have not independently
verified this information.
<TABLE>
<CAPTION>
Shares of
Principal amount common Percentage of
of notes owned Percentage stock that common stock
Name that may be sold of notes may be sold/1/ outstanding/2/
---------------------- ---------------- ---------- -------------- -------------
<S> <C> <C> <C> <C>
Lehman Brothers, Inc. $3,650,000 1.1% 111,246 *
</TABLE>
Other than its ownership of our securities, this selling securityholder has
not had any material relationship with us within the past three years.
____________________
* Less than 1%.
1. Assumes conversion of the full amount of notes owned by each selling
securityholder at the initial conversion price of $32.81 per share. Under the
terms of the indenture governing the notes, cash will be paid instead of issuing
fractional shares upon conversion.
2. Based on 81,565,215 shares of our common stock outstanding at June 30,
2000. In accordance with the rules of the SEC, the percentage of common stock
outstanding owned by each selling securityholder is computed as follows: (a) the
numerator is the number of shares of common stock held by that selling
securityholder upon conversion of all notes owned by that selling securityholder
and (b) the denominator includes the number of shares of common stock
outstanding and the number of shares of common stock held by that selling
securityholder upon conversion of all notes owned by that selling
securityholder.
